Tag: growth,

Global Face Mask Market Size, Share, Price, Trends, Growth, Analysis, Report And Forecast 2023-2028

Wpis z dnia Zamieszczone w Bez kategoriiOtagowano , , , , , , , , , , , , , , Dodaj komentarz

The new report by Expert Market Research titled, ‘‘Global Face Mask Market Size, Share, Price, Trends, Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the global face mask market, assessing the market based on its segments like type, materials, nature, distribution channels, and major regions like North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/face-mask-market/requestsample

The key highlights of the report include:

Market Overview (2023-2028)

  • Historical Market Value (2020): USD 20.6 billion

The COVID-19 pandemic is presently sweeping the globe. Coronavirus infection can cause multiple organ failure, acute and severe respiratory difficulties, pneumonia, and even death. As a result, an increase in the number of people infected with the coronavirus is predicted to boost the global face mask market. Face masks are critical for controlling infectious diseases, especially when it comes to preventing droplet transmission.

A surgical face mask is quite effective in avoiding SARS transmission. The global face mask market is predicted to expand due to an increase in the usage of surgical face masks. The global surgical face mask market is expected to grow as a consequence of a greater emphasis on the production of protective equipment, such as face masks, as a result of increased knowledge of preventative care.

Following an initial surge in demand for face masks during the COVID-19 outbreak, the market is likely to slow throughout the forecast period. Furthermore, the increased availability of face masks is projected to impede market growth in the approaching years. Furthermore, growing face mask prices are projected to stymie the global face mask sector.

Face Mask Industry Definition and Major Segments

A face mask is a covering that a human wears over one’s face, for example, to prevent poor air from entering the lungs or germs from spreading, or to protect one’s face in a dangerous circumstance.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/face-mask-market

Based on type, the market is bifurcated into:

  • Surgical Mask
  • Dust Mask
  • N95 Respirators

Based on material, the market is divided into:

  • Cotton
  • Polypropylene
  • Others

Based on nature, the market is categorised into:

  • Reusable
  • Disposable

Based on distribution channels, the market is segmented into:

  • Direct Distribution
  • Retail Distribution

The regional markets for global face mask market panel:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Face Mask Market Trends

Increased penetration of multiple online portals in emerging markets, as well as an increase in the number of offers or discounts, motivates consumers to purchase face masks via online channels. This has contributed to the expansion of the face mask industry. Furthermore, as the internet sales channel has increased client reach, it has become a significant source of revenue for many organisations. Furthermore, the online sales business is expected to grow in the near future due to significant growth in internet and mobile user bases in emerging economies. Increased e-commerce sales, better logistical services, easier payment options, and the potential for large businesses to reach out to new customers.

Key Market Players

The major players in the market are 3M Company, Alpha Pro Tech Ltd, Cambridge Mask Co, Cardinal Health Inc, Honeywell International Inc, Kimberly-Clark Worldwide Inc, Moldex-Metric Inc, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, mergers and acquisitions, among other latest developments of these market players.

Related Reports:

Circuit Breaker Market: https://www.expertmarketresearch.com/reports/circuit-breaker-market

Digital Therapeutics Market: https://www.expertmarketresearch.com/reports/digital-therapeutics-market

Pet Insurance Market: https://www.expertmarketresearch.com/reports/pet-insurance-market

Digital Transformation Market: https://www.expertmarketresearch.com/reports/digital-transformation-market

Face Mask Market: https://www.expertmarketresearch.com/reports/face-mask-market

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Anisha Luccas, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
LinkedIn: https://www.linkedin.com/company/expert-market-research

Hand Sanitizer Market Growth, Analysis, Size, Trends, Emerging Factors, Demands, Key Players, Emerging Technologies and Potential of Industry Till 2028

Wpis z dnia Zamieszczone w Bez kategoriiOtagowano , , , , , , , , , , , , , Dodaj komentarz

The global hand sanitizer market size was valued at USD 2.98 billion in 2020 and reached USD 2.79 billion in 2021. The market size is expected to reach USD 3.47 billion by 2028, exhibiting a CAGR of 3.1% during the forecast period. Innovators and business people across the globe are rehashing their plans of action considering the Covid pandemic. In the craft cocktail arena, breweries and distilleries are transitioning their focus from spirits to hand sanitizers. For example, in May 2020, Doctor Shultz’s, collaborated with Ilthy, a dress brand for assembling and providing hand sanitizers and face masks.

Furthermore, increasing awareness regarding cleanliness practices and strong demand for the product for the development of personal care products may enhance industry growth. Fortune Business Insights™ provides this information in its report titled “Hand Sanitizer Market, 2021-2028”

List of major companies profiled in the hand sanitizer market are:

  • Reckitt Benckiser Group Plc (U.K.)
  • Gojo Industry Inc. (U.S.)
  • Henkel AG & Company (Germany)
  • Himalaya Global Holdings Ltd. (India)
  • Unilever Plc. (U.K.)
  • Bacardi Limited (Bermuda)
  • CVS Health (U.S.)
  • Best Sanitizer Inc. (U.S.)
  • Proctor & Gamble (U.S.)
  • SC Johnson & Son, Inc. (U.S.)

Report Coverage

The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market’s key players.

The hand sanitizer market is profoundly divided with the presence of an enormous number of territorial and nearby players. The market players face extraordinary rivalry, particularly from the top producers of this market as they have an enormous buyer base, solid memorability, and tremendous conveyance organizations. Organizations have been carrying out different development methodologies, for example, associations and new item dispatches, to remain ahead in the game.

Drivers and Restraints

Strong Government Support for the Promotion of Hygiene Products to Propel Industry Progress

Hand sanitizers are anti-infection solutions that eliminate germs and viruses efficiently. Strong governmental support for hygiene products’ promotion may enhance hand sanitizer adoption. For example, the World Health Organization (WHO) announced a campaign titled “Seconds Save Lives, Clean your Hands” to promote hand hygiene awareness among the people. Further, the rising infrastructural facilities such as specialty stores, shopping malls, and retail outlets are expected to enhance hand sanitizers’ adoption. Further, the rising consumer preferences toward beauty and healthcare products may drive the hand sanitizer market growth.

However, the abundance of alternative products may hamper the industry’s growth.

Segmentation

Gel Segment to Hold Major Share Attributable to its Effective Germ Protection

By product form, the market is segmented into liquid, gel, and foam.

The gel segment is expected to grow rapidly due to its effective germ protection. Furthermore, its ability to easily spread on hands enhanced hand sanitizer sales. Moreover, quicker sanitization and drying property of gels may enhance segmental growth.

Alcohol-Based Sanitizers to Dominate Owing to Rapid Adoption in Hospitals

By type, the market is bifurcated into alcohol-free and alcohol-based sanitizers.

The alcohol-based sanitizer segment is expected to hold a dominant market share because of its extensive adoption in hospitals and effectiveness in germ elimination. Furthermore, the anti-microbial ability of alcohol-based sanitizers may incite industry growth

Supermarket/hypermarket Stores Segment to Dominate Owing to the Availability of a Wide Variety of Products

By distribution channel, the market is categorized into online retail, supermarkets/hypermarkets, pharmacy stores, and others.

The supermarkets/hypermarkets segment is expected to dominate owing to the availability of various products. Furthermore, the availability of discounts is expected to enhance product demand.

Hospital Segment to Dominate Attributable to Strong Demand for Sanitizers

By end-user, it is classified into households, hospitals, restaurants, schools, and others.

The hospital segment is expected to hold a dominant market share due to the strong demand for sanitizers to maintain a clean and hygienic environment. Moreover, the rising health concerns among staff and doctors in clinics and hospitals may elevate demand.

Regionally, it is clubbed into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

Regional Insights

Presence of Prominent Players to Propel Market Progress in North America

North America is expected to dominate the hand sanitizer market share because of the presence of prominent players. The market in North America stood at USD 1.38 billion in 2020 and is likely to gain a huge portion of the global market share in the upcoming years. Furthermore, rising sanitization practices and personal hygiene is expected to bolster industry growth.

In Europe, efficient medical facilities are expected to enhance hand sanitizer adoption. As per the State of the Health in the EU, Italy, France, Italy, and Spain have excellent medical facilities compared to other European countries. These factors may enhance the market growth.

In Asia Pacific, the strong adoption of personal care products is expected to boost market progress. As per the ‘China Consumer Market 2019’ report, personal care product sales increased nearly 8 times in 2019. In addition, rising government initiatives for developing programs associated with personal care products in India are expected to propel market growth.

Competitive Landscape

Major Players Launch Novel Products to Boost Brand Image

The prominent companies operating in the market announce novel products to boost brand image. For example, Cavinkare announced cost-effective products under the Nyle, Raaga, and CHIK brands in March 2020. This development aims to provide hygiene solutions to people suffering from disease-causing bacteria and viruses. This strategy may allow the company to enhance its brand image. Furthermore, companies adopt novel product launches, mergers, acquisitions, and expansions to strengthen their market position.

Key Industry Development

  • April 2020- Nycil announced sanitizer products under its ‘germ protection for family’ category for business expansion during the pandemic.

Browse Detailed Summary of Research Report:

https://www.fortunebusinessinsights.com/hand-sanitizer-market-102710

Ice Maker Market Share, Size, Trends, Growth, Analysis, Report, Forecast 2023-2028

Wpis z dnia Zamieszczone w Bez kategoriiOtagowano , , , , , , , , , , , , Dodaj komentarz

The ‘Global Ice Maker Market Size, Price, Trends, Growth, Analysis, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global ice maker market, assessing the market on the basis of its segments like product types, end uses, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Ice Maker Market Size, Share, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 6.2%

An ice maker enables the production of large amounts of ice which brings redundance to the need of pilling up ice stocks for occasions or other forms of high-volume usage. Hence, this appliance is witnessing a heightened demands in the foodservice sector. Ice makers are easy to operate and are hygienic, which is a major advantage propelling the demand for this product. Restaurants, cafes, and various food service businesses use ice in beverages and to preserve meats and various frozen grocery products. As a result, the dependence of food service businesses on ice makers is bolstering the global ice maker market.

Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/ice-maker-market/requestsample

Ice makers also finds application in the healthcare sector to preserve tissues, samples, organs, and facilitate ice therapy. Preservation of tissues and samples requires ice, as does the preservation of organs before transplant. The increasing prevalence of inflammation and abnormal blood pressure among the geriatric patients is fuelling the demand for ice in bulk, leading to an increased incorporation of industrial ice makers across physical therapy clinics and large hospitals.

North America holds a significant share in the market. The large number of beverage consumers, food service businesses, and frozen food consumers are generating a remarkable demand for ice and the ice maker market.

Ice Maker Industry Definition and Major Segments

An ice maker, also known as an ice generator, is defined as a dedicated appliance which produces ice . There are many types of ice makers available, to produce ice of different shapes, sizes, and volumes. Ice makers are useful for households, food service businesses, pharmaceuticals, and other end users. The key components constituting an ice maker include a compressor, condenser, and an evaporator.

Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/ice-maker-market

Based on product type, the market can be segmented into:

• Ice Cube Maker
• Ice Flake Maker
• Ice Nugget Maker
• Others

The end uses included in the market are as follows:

• Food Service
• Retail
• Healthcare
• Residential
• Others

On the basis of region, the market can be categorised into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Ice Maker Market Trends

The key trends in the ice maker market include the rapid innovations and progressive product developments which are bolstering the popularity of ice makers. For instance, countertop ice makers are popular owing to its compact design that saves space.

Innovative ice makers which produce attractive ice shapes along with excellent symmetry are gaining traction among the cocktail enthusiasts and mixologists. This trend is further bolstered by the increasing popularity of non-alcoholic cocktails, increasing consumption of beer, and rising footfall in pubs and beverage shops, leading to a greater growth of the global ice maker market. Moreover, the development of noise-free, quick, and portable ice makers is a crucial trend adding to the market growth.

Key Market Players

The major players in the ice maker market report are

  • Hoshizaki America, Inc.
  • Scotsman Ice Systems
  • Manitowoc Ice
  • Newair
  • Cornelius, Inc.
  • Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports:-

Low Voltage Motor Control Centre Market- https://www.expertmarketresearch.com/reports/low-voltage-motor-control-centre-market

Cocoa Solids Market- https://www.expertmarketresearch.com/reports/cocoa-solids-market

Boiler Refractory Material Market- https://www.expertmarketresearch.com/reports/boiler-refractory-material-market

Energy Recovery Ventilator Market- https://www.expertmarketresearch.com/reports/energy-recovery-ventilator-market

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over  3,000 EMR  consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact

Company Name: Claight Corporation
Contact Person: Ana John, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

Cystic Fibrosis Therapeutics Market shall reach US$ 24.35 Billion by 2028, Size, Share, Growth | Renub Research

Wpis z dnia Zamieszczone w sukcesOtagowano , , , , , , , , , , , , , , , Dodaj komentarz

 

Renub Research has recently released a report named “Cystic Fibrosis Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Company Analysis” providing a detailed industry analysis that consists of market share insights. In addition, the report covers research on competitors and areas and current advancements in the Cystic Fibrosis Therapeutics Market.

The Cystic Fibrosis Therapeutics Market shall reach US$ 24.35 Billion by 2028. A genetic disorder that impacts the respiratory, digestive, and reproductive systems, cystic fibrosis can be managed with various therapeutic options, including medications, airway clearance techniques, exercise programs, nutritional support, and a lung transplant as a last resort. In addition, recent advances in the field have led to the development of novel therapies like gene therapies and modulators, significantly improving treatment outcomes for individuals with cystic fibrosis.

American Lung Association reports that around 30,000 individuals in the United States and 70,000 individuals worldwide are affected by cystic fibrosis, with approximately 1 in 30 Americans carrying the gene mutation that causes the condition

The growing prevalence of cystic fibrosis is driving demand for treatments. At the same time, medical research has led to the development of innovative therapies, including gene therapies and modulators that improve patient outcomes. As a result, pharmaceutical companies are investing in cystic fibrosis therapeutics due to the potential for market profitability and unmet medical needs. In addition, governments and regulatory agencies are incentivizing research and development and simplifying the approval process, further fuelling growth in the market.

Report Details:

Report Features Details
Base Year 2022
Historical Period 2017 – 2022
Forecast Period 2023 – 2028
Market US$ Billion
Segment Covered Route of Administration, Treatment, Test Type, Distribution, Drug Class, Region
Regions Covered North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Companies Covered Vertex Pharmaceuticals, Abbvie Inc., Novartis Ag, Gilead Sciences, Viatris INC, Pfizer and Astrazeneca
Customization Scope 20% Free Customization
Post-Sale Analyst Support 1 Year (52 Weeks)
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

 

During the forecast period, the inhale segment shall capture the largest share of the cystic fibrosis therapeutics market

Inhaling medications provides a targeted and direct approach to treating the respiratory symptoms of cystic fibrosis. Secondly, inhaled therapies allow for higher lung drug concentrations with fewer systemic side effects. Thirdly, patients and physicians prefer inhaled medicines due to their convenience and ease of administration. Finally, advancements in inhalation technology, including nebulizers and dry powder inhalers, have significantly improved drug delivery and efficacy.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=cystic-fibrosis-therapeutics-market-p.php

Route of Administration – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 2 Viewpoints

  1. Oral
  2. Inhale

Devices account for a substantial portion of the revenue in the cystic fibrosis therapeutics market due to their extensive availability and ease of use for patients

Firstly, the growth of the devices segment in the cystic fibrosis therapeutics market is driven by the increasing demand for patient-friendly and portable devices that individuals at home can use. Secondly, the development of more efficient and practical devices, such as smart inhalers and vibrating vests, due to technological advancements is improving treatment outcomes for patients. Thirdly, the demand for devices that can monitor and adjust treatment plans for individual patients, thereby improving efficacy, is driven by the trend towards personalized medicine. Lastly, the increasing prevalence of cystic fibrosis worldwide also significantly contributes to the demand for devices to manage disease symptoms.

Treatment – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 3 Viewpoints

  1. Medication
  2. Devices
  3. Other Treatment

Pulmonary function test type holds a significant share in the cystic fibrosis therapeutics market categorized by test type

Pulmonary Function Tests (PFTs) are critical for evaluating lung function in people with cystic fibrosis. They measure lung capacity, airflow, and gas exchange, essential for monitoring disease progression and treatment effectiveness. PFTs are a standard of care in cystic fibrosis diagnosis and management, recommended by medical guidelines for routine clinical practice. They determine appropriate treatment plans and provide valuable information on disease severity. Technological advancements have improved the accuracy and efficiency of PFT devices. Also, the increasing global prevalence of cystic fibrosis drives the demand for PFTs as reliable diagnostic tools.

Test Type – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 5 Viewpoints

  1. Plumonary Function
  2. Sweat Calories
  3. IRT Test
  4. Faceal Tests
  5. Genetic Tests

Hospitals dominate the cystic fibrosis therapeutics market due to increasing demand for accurate diagnosis and follow-up treatments under medical supervision

The maximum revenue in the cystic fibrosis therapeutics market is held by hospitals, mainly due to the increasing demand for accurate diagnosis and follow-up treatments under medical supervision. Therefore, there is growth in the number of hospital visits by patients, which drives the development of the hospital segment. Additionally, hospital pharmacies generate significant earnings since patients infected with cystic fibrosis typically visit nearby hospitals for doctor’s appointments and prescription medicines.

Distribution – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 3 Viewpoints

  1. Hospital
  2. Retail Pharmacies
  3. Others

CFTR modulators drug class shall generate the highest revenue in the upcoming years

The CFTR Modulators Drug class comprises specialized therapies that improve the functional expression of CFTR mutants, approved for clinical use in people with specific CF genotypes. They have demonstrated high effectiveness in modifying the disease course for most CF patients. Additionally, advanced experimental approaches have been developed to hasten the creation of new modulators, likely to contribute to the growth of the Cystic Fibrosis Therapeutics Market.

Drug Class – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 4 Viewpoints

  1. Pancreatic Enzyme Supplements
  2. Mucolytics
  3. Bronchodilators
  4. CFTR Modulators

In the forecast period, North America will have sovereignty in the cystic fibrosis therapeutics market, capturing the largest share

North America’s dominance in the cystic fibrosis therapeutics market can be attributed to various factors, including a higher prevalence of the disease, advanced healthcare infrastructure, favorable regulatory environment for drug development, streamlined drug approval processes by the FDA, technological advancements in cystic fibrosis therapeutics, and high healthcare spending. These factors have created a conducive environment for the development and adoption of innovative therapies and treatments for cystic fibrosis in North America, resulting in the region’s overall revenue dominance in the market.

Region – Cystic Fibrosis Therapeutics Market Analysis have been Covered from 5 Viewpoints

  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa

Competitive Landscape

Vertex Pharmaceuticals, Abbvie Inc., Novartis Ag, Gilead Sciences, Viatris INC, Pfizer, and AstraZeneca are the major players in the Cystic Fibrosis Therapeutics Market.

All companies have been covered from 3 viewpoints

  • Overviews
  • Recent Developments
  • Revenues

Company

  1. Vertex Pharmaceuticals
  2. Abbvie Inc.
  3. Novartis Ag
  4. Gilead Sciences
  5. Viatris INC
  6. Pfizer
  7. Astrazeneca

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Alzheimer’s Drug Market to Reach US$ 7.48 Billion by 2027: Opportunities and Growth Forecast | Renub Research

Wpis z dnia Zamieszczone w sukcesOtagowano , , , , , , , , , , , Dodaj komentarz

Renub Research has recently released a report named “Alzheimer’s Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis” providing a detailed industry analysis that consists of market share insights. In addition, the report covers research on competitors and areas and current advancements in the Alzheimer’s Drug Market. The Alzheimer’s Drug Market shall expand at a CAGR of nearly 7.71%. Alzheimer’s is a degenerative neurological disorder causing cognitive decline, memory loss, and behavioural changes, accounting for 60-80% of dementia cases. Its exact causes are unknown but may involve genetic, environmental, and lifestyle factors, leading to brain cell damage, shrinking of brain tissue, and protein build-up. While no cure exists, treatments can improve quality of life and delay symptom onset with early detection and care.

Report Details:

Report Features Details
Base Year 2022
Historical Period 2018 – 2022
Forecast Period 2023 – 2027
Market US$ Billion
Segment Covered Drug Class, End-User, and Region
Region Covered North America, Europe, Asia Pacific and Rest of World
Companies Covered Sanofi SA, F. Hoffman-La Roche Ltd., Pfizer Inc., Abbott Laboratories, Bayer, Merck & Co., BoehringerIngelheim GmbH, GlaxoSmithKline Plc., Novartis, Eli Lilly and Company, and Teva Pharmaceuticals
Customization Scope 20% Free Customization
Post-Sale Analyst Support 1 Year (52 Weeks)
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

 

Dementiastatistics.org estimates that approximately 55.2 million individuals worldwide are affected by dementia, with the majority being individuals over 60.The rising incidence of Alzheimer’s disease, particularly among the aging population, has led to a higher demand for Alzheimer’s drugs as the global population ages. In addition, the high unmet medical needs for more effective treatments, advancements in research and development of new medications and treatment options, and government initiatives and funding for research have all contributed to the growth of the Alzheimer’s drug market. However, Alzheimer’s disease is poorly understood, which makes it challenging to develop effective drugs targeting its underlying mechanisms. In addition, high clinical trial failure rates and strict regulatory processes limit drug approval, while the expenses of medicines and limited insurance coverage limit access for some patients.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=alzheimer-s-pipeline-drugs-review-alzheimer-s-disease-drug-market-and-forecast-global-analysis-131-p.php

Alzheimer’s drug market for Donepezil drug shall grow further during the forecast period

Donepezil is an acetylcholinesterase inhibitor utilized in the treatment of Alzheimer’s disease, and the increasing prevalence of the disease, the aging population, and the high unmet medical needs primarily drive its growth in the Alzheimer’s drug market. The drug is one of the most commonly prescribed medications for Alzheimer’s disease and has demonstrated significant benefits in managing cognitive symptoms in patients. In addition, ongoing research, and development activities to improve the effectiveness of Donepezil and expand its applications in treating other neurological disorders are also contributing to its market growth.

Product – Alzheimer’s Drug Market breakup from 5 viewpoints

  1. Donepezil
  2. Galantamine
  3. Rivastigmine
  4. Memantine
  5. Others

Dominance of the hospital segment in the market can be due to the increasing hospitalization rates of older individuals and patients with Alzheimer’s disease

The increasing prevalence of Alzheimer’s disease among the aging population has led to more patients requiring hospitalization and specialized care. Additionally, hospitals have advanced medical facilities that can provide more effective and comprehensive treatment for Alzheimer’s patients. Moreover, hospital-based treatment approaches for Alzheimer’s are becoming more widely adopted, as hospitals can offer various services such as diagnostics, medication management, and rehabilitation. Lastly, supportive government initiatives aimed at improving hospital infrastructure and providing better healthcare services for the older and patients with Alzheimer’s disease have also contributed to the dominance of the hospital segment in the Alzheimer’s drug market.

End User – Alzheimer’s Drug Market breakup from 4 viewpoints

  1. Hospitals
  2. Clinics
  3. Nursing homes
  4. Homecare Centres

North America shall have the largest market share in the Alzheimer’s drug market

North America’s leading position in the Alzheimer’s drug market can be due to its large aging population, which increases the risk of developing the disease. According to the American Association, over 6 million Americans of all ages have Alzheimer’s, with a gauge of 6.7 million Americans age 65 and older living with the disease in 2023. Of those, 73% are 75 or older, and around 1 in 9 people 65 and older (10.7%) have Alzheimer’s.

North America’s dominance in the Alzheimer’s drug market is due to several reasons, such as its well-developed healthcare infrastructure, advanced medical facilities, skilled workforce, and high level of awareness and education about Alzheimer’s disease. Additionally, the region has an intense research and development base for Alzheimer’s drugs, with many pharmaceutical companies and academic institutions conducting research in this field. Supportive government initiatives and funding for Alzheimer’s research and treatment have also contributed to North America’s leadership in the Alzheimer’s drug market.

Region – Alzheimer’s Drug Market breakup from 4 Regions

  1. North America
  2. Europe
  3. Asia-Pacific
  4. Rest of the World

Competitive Landscape

All the key players in the Alzheimer’s drug market businesses invest in research and development activities and introduce new products to expand their share in the Alzheimer’s drug markets.

All key players have been covered from 3 viewpoints:

  1. Overview
  2. Strategy
  3. Financial Insight

Company Analysis:

  1. Sanofi SA
  2. F. Hoffmann-La Roche Ltd.
  3. Pfizer, Inc.
  4. Abbott Laboratories
  5. Bayer
  6. Merck & Co.
  7. BoehringerIngelheim GmbH
  8. GlaxoSmithKline Plc.
  9. Novartis
  10. Eli Lilly and Company
  11. Teva Pharmaceuticals

Browse Related Report:

United States Generic Drugs Market: https://www.renub.com/united-states-generic-drugs-market-p.php

Coronary Artery Disease Market: https://www.renub.com/coronary-artery-disease-market-p.php

Cancer Pain Management Market: https://www.renub.com/cancer-pain-management-market-p.php

Hormone Replacement Therapy Market: https://www.renub.com/hormone-replacement-therapy-market-p.php

Diabetes Drug Market: https://www.renub.com/diabetes-drug-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

External Defibrillator Market Share, Size, Growth, Analysis, Report, Forecast 2023-2028

Wpis z dnia Zamieszczone w Bez kategoriiOtagowano , , , , , , , , , , , , Dodaj komentarz

The new report by Expert Market Research titled, ‘Global External Defibrillator Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2023-2028’, gives an in-depth analysis of the global external defibrillator market, assessing the market based on its segments like products, end-uses, and major regions.

The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028):8.8%

The global market is expected to be driven by the rising need to respond to cardiac arrest emergencies. A rise in focus on public access defibrillators (PAD) by public and private organisations is fuelling the external defibrillators market growth. Also, the expanding number of major players in the development of advanced defibrillator devices, the rapidly growing geriatric population with an increased risk of cardiac arrest, and the rising frequency of cardiac disorders are fuelling the market expansion.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/external-defibrillator-market/requestsample

Growing awareness regarding cardiovascular events in developing markets is another key driver for the market. Additionally, the growing geriatric population is increasing the prevalence of all types of chronic disorders, which in turn, affect the heart. This is increasing the number of automated external defibrillators (AEDs) installed in hospitals, pre-hospital care settings, and even primary-care clinics.

Industry Definition and Major Segments

Defibrillators are medical devices that give therapeutic shocks to the patient’s heart in life-threatening disorders, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. External defibrillators are life-saving medical devices that employ paddles or electrode pads to deliver defibrillating shocks to identify and repair life-threatening irregular heart rhythms in situations of unexpected cardiac arrest.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/external-defibrillator-market

By product, the global external defibrillator market is divided into:

• Wearable Cardioverter Defibrillators
• Implantable Cardioverter Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators
o Semi-Automated ED
o Fully Automated ED

The end-uses of the market are:

• Pre-Hospital
• Public Access Market
• Hospital
• Home Healthcare
• Alternate Care Market

On the basis of region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Trends

An increase in the adoption of technologically advanced defibrillator devices and a rise in demand for quality medical care are the key factors for the growth of the external defibrillator market. The growing emphasis on the installation of defibrillators in public locations, and the availability of defibrillators in offices, schools, shopping malls, grocery shops, and airports, drives the market expansion.

Further, increasing focus by leading market participants on public access to defibrillators and an increase in the number of training and awareness programmes around the world are a few factors driving the growth of the external defibrillators market. Developments in the creation of next-generation external defibrillators to improve safety and effectiveness are expected to provide lucrative market prospects.

Key Market Players

The major players in the marketare Koninklijke Philips N.V., Stryker Corporation, ZOLL Medical Corporation, Nihon Kohden Corporation, and Boston Scientific Corporation, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports:-

Peru Flavours Market- https://www.expertmarketresearch.com/reports/peru-flavours-market

Dengue Testing Market- https://www.expertmarketresearch.com/reports/global-dengue-testing-market

Industrial Air Blower Market- https://www.expertmarketresearch.com/reports/industrial-air-blower-market

Graphene Nanoplatelets Market- https://www.expertmarketresearch.com/reports/graphene-nanoplatelets-market

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact

Company Name: Claight Corporation
Contact Person: Ana John, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

Canopy Growth sheds assets in Canada, plans more layoffs

Wpis z dnia Zamieszczone w Bez kategoriiOtagowano , , , , , , , ,

By Ankit Kumar

Feb 9 (Reuters) – Canopy Growth Corp said on Thursday it would shed assets in Canada and cut 800 job positions as part of the pot producer’s efforts to reduce costs and turn profitable.

Shares of the company, which reported a bigger quarterly loss, evDEN EVE nAKliyAT plunged 16.6% to C$3. If you loved this article and you wish to receive details regarding EVDEn eVe nAkLiYaT assure visit our page. 06 at the closing of trade.

The company has been cutting costs through layoffs, exit from some international markets, store closures and divestiture of its retail business across Canada.

The company expects to save C$140 million ($104.10 million)to C$160 million over the next 12 months.

Its streamlining efforts in Canada include exiting cannabis flower cultivation in its Smiths Falls, Ontario facility, ceasing the sourcing of cannabis flower from the Quebec facility, and EVdEN EVe naKliYat moving to a third-party sourcing model for cannabis beverages, edibles, vapes and extracts.

The company expects to complete the operational changes in the second quarter of fiscal 2024 and record restructuring-related pretax charges of C$425 million to C$525 million in the current quarter and the first half of fiscal 2024.

Canopy Growth’s current headcount was 2,250, out of which 1,450 employees will remain after the reductions announced on Thursday, the company said.

“Canopy is now in a position where its success will largely depend on investor enthusiasm amid an environment where cannabis sentiment is at best apathetic,” Stifel analyst Andrew Carter said in a note.

The company’s adjusted core loss widened to C$87.5 million in the quarter ended Dec.

31, evden evE NakLiyAT from C$67.4 million a year earlier.

Smaller rival Aurora Cannabis Inc, however, reported an adjusted core profit of C$1.4 million, compared to a loss of C$7.1 million in the year-ago quarter, helped by higher revenue and reduction in expenses.
($1 = 1.3449 Canadian dollars) (Reporting by Ankit Kumar, additional reporting by Sourasis Bose; Editing by Maju Samuel and Shailesh Kuber)